GSK says U.S. FDA wants more information on pulmonary drug

LONDON (Reuters) – GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease (COPD). FILE PHOTO: The GlaxoSmithKline (GSK) logo. March 21, 2018. REUTERS/Loriene Perera/File Photo GSK said it had received a complete response letter (CRL) from the U.S. Food… Read More »

Deaf-Owned Eateries Forge Path To Fight Joblessness Among Those With Hearing Loss

Mozzeria is one of the most talked-about pizzerias in the heart of a vibrant San Francisco neighborhood. Every staff member employed at the restaurant identifies as deaf or hard of hearing. Courtesy of Mozzeria, San Francisco hide caption toggle caption Courtesy of Mozzeria, San Francisco Mozzeria is one of the most talked-about pizzerias in the… Read More »

Weekly Roundup for AUGUST 24, 2018: Recent Publications in Women’s Mental Health

This week, we have some data from our National Pregnancy Registry of Psychiatric Medications looking at infants exposed to quetiapine (Seroquel).  Consistent with other studies we have seen recently, there appears to be no increase in risk of major malformations.  There is also an interesting paper from DiFlorio and colleagues which assesses risk for postpartum… Read More »